Reasons why access cannot be provided (enquiries for GSK studies)
Reason |
Number of studies |
No data available |
29 |
GSK does not have the legal authority |
21 |
Not accepted for publication |
22 |
Foreign language |
9 |
Medicine not approved or terminated * |
3 |
Rare disease study with risk of re-identification |
2 |
Patient informed consent form restriction
|
0 |
*Applicable up to April 2016
618 |
GSK |
633 |
GSK |
690 |
GSK |
938 |
BI/GSK/Roche |
941 |
Roche |
1047 |
GSK |
1087 |
GSK |
1107 |
GSK |
1589 |
Novartis |
Proposal number
|
Study Sponsor(s)/funder(s)
|
Reason(s)
|
615 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
618 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
633 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
690 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
931 |
BI/GSK |
The Research Proposal did not meet the Sponsor
policies for informed consent |
938 |
BI/GSK/Roche |
The Research Proposal is not seeking access to
anonymised patient level data |
941 |
Roche |
The Research Proposal is not seeking access to
anonymised patient level data |
1047 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
1087 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
1107 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
1552 |
Novartis |
The proposed research required data that was not collected in the studies requested |
1235 |
BI |
The Research Proposal competes with the Sponsor's publication plan |
1245 |
BI |
The Research Proposal competes with the Sponsor's publication plan |
1589 |
Novartis |
The Research Proposal is not seeking access to anonymised patient level data |